Additionally, there is an increasing need for clinical-stage Bioreactors due to increased R&D efforts worldwide for the development of preventive vaccines. For instance, Serum Institute of India Pvt. Ltd. (SIIPL) used CSR Bioreactors from ABEC to manufacture the COVID-19 vaccine. Therefore, the Bioreactors Market will continue to expand significantly during the projection period as more manufacturing facilities adopt Bioreactors. Yeast cells, mammalian cells, bacterial cells, and animal cells can all grow in Bioreactors under carefully controlled conditions. These Bioreactors are primarily used in manufacturing pharmaceutical products, such as monoclonal antibodies and vaccines. The adoption of bioreactor products in the healthcare sector is being driven by their broad applications in the commercial production of biologicals.
Watch the Video for more details- https://lumen5.com/user/poojasalve/bioreactors-market-je2gp/
